[1] Ruggiero SL, Dodson TB, Fantasia J, et al.American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update[J]. J Oral Maxillofac Surg. 2014, 72(10):1938-1956. [2] Ruggiero SL, Dodson TB, Aghaloo T, et al.American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update[J]. J Oral Maxillofac Surg, 2022, 80(5):920-943. [3] 何悦, 陈珩, 安金刚, 等. 药物相关性颌骨坏死临床诊疗专家共识[J]. 中国口腔颌面外科杂志, 2023, 21(4):313-325. [4] Ruan HJ, Chen H, Hou JS, et al.Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw[J]. J Bone Oncol, 2024, 49:100650. [5] Marx RE.Pamidronate (Aredia) and zoledronate(Zometa) induced avascular necrosis of the jaws: A growing epidemic[J]. J Oral Maxillofac Surg, 2003, 61(9):1115-1117. [6] Bracchi P, Zecca E, Brunelli C, et al.A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab[J]. Cancer Med, 2023, 12(17):18317-18326. [7] Limones A, Sáez-Alcaide LM, Díaz-Parreño SA, et al.Medication-related osteonecrosis of the jaws(MRONJ)in cancer patients treated with denosumab VS.zoledronic acid:A systematic review and meta-analysis[J]. Med Oral Patol Oral Cir Bucal, 2020, 25(3):e326-e336. [8] 魏斌, 孙国文. 双膦酸盐及其相关性颌骨坏死的机制和治疗[J]. 国际口腔医学杂志, 2016, 43(4):445-448. [9] 孙国文, 田美. 药物相关性颌骨坏死不同阶段治疗方法述评[J]. 口腔颌面外科杂志, 2022, 32(3):135-143. [10] 侯伟, 董肖婷, 吴婷婷, 等. 药物相关性颌骨坏死的病因特点和临床治疗初探[J]. 中华口腔医学杂志, 2021, 56(7):659-664. [11] 李梦媛, 郭玉兴, 张新华. 药物相关性颌骨坏死术后软组织创口闭合技术的临床研究进展[J]. 国际口腔医学杂志, 2025, 52(2):263-271. [12] 中华口腔医学会口腔颌面修复专业委员会. 下颌骨缺损修复重建治疗专家共识[J]. 中华口腔医学杂志, 2019, 54(7):433-439. [13] Kim RY, Sokoya M, Ducic Y, et al.Free-flap reconstruction of the mandible[J]. Semin Plastic Surg, 2019, 33(1):46-53. [14] Sacco R, Umar G, Guerra RC, et al.Evaluation of segmental mandibular resection without microvascularreconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review[J]. Br J Oral Maxillofac Surg, 2021, 59(6):648-660. [15] 徐骏疾, 周建, 王松灵. 放射性及双膦酸盐相关性颌骨坏死的发病机制及治疗进展[J]. 中华口腔医学杂志, 2021, 56(5):404-409. [16] Kumar BP, Venkatesh V, Kumar KA, et al.Mandibular reconstruction:overview[J]. J Maxillofac Oral Surg, 2016, 15(4):425-441. [17] Weber JB, Camilotti RS, Ponte ME.Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): A systematic review[J]. Lasers Med Sci, 2016, 31(6):1261-1272. [18] 马亮, 刘鹤. 经鼻低强度红外激光联合鼻腔冲洗治疗过敏性鼻炎患者的临床效果及对其炎性因子的影响分析[J]. 临床医学工程, 2025, 32(4):427-430. [19] 赵彤霞, 柳康, 李亚华, 等. 上颌翼状导板在下颌骨缺损修复中的应用[J]. 中国老年学杂志, 2020, 40(13):2786-2789. [20] MückeT, Jung M, Koerdt S, et al. Free flap reconstruction for patients with bisphosphonate related osteonecrosis of the jaws after mandibulectomy[J]. J Craniomaxilofac Surg, 2016, 44(2):142-147. |